Archive for February, 2007

Sarasota’s Roskamp Institute Announces Participation in Multiple Sclerosis Study

We have just put out a press release announcing the Roskamp Institute’s participation in a multiple sclerosis study.

Here’s a quote from Michael Mullan:

“We are looking for volunteers to participate in this pharmaceutical sponsored research study to assess the effectiveness and safety of the investigational drug fingolimod, used to treat patients with relapsing-remitting MS,” said Dr. Michael Mullan, director of the Roskamp Institute. “We hope by working with Novartis we may be able to provide our patients and their families with another treatment option.”

alzheimers michael mullan 

Advertisements

Roskamp Institute recruiting for clinical trials

One of the key aspects of our research at the Roskamp Institute is clinical trials.  Without qualified volunteers, our work is impossible.

We are currently recruiting volunteers for our clinical trials, which are run by our Scientific Director, Michael Mullan, MBBS, Ph.D.  We are currently recruiting for clinical trials on the following diseases.

  • Alzheimer’s Disease
  • Dementia
  • Mild Cognitive Impairment (MCI)
  • Depression
  • Epilepsy
  • Head and Traumatic Brain Injury
  • Migraine
  • Multiple Sclerosis with or without Spasticity
  • Neurodegenerative disease
  • Neuromuscular disorders
  • Parkinson’s Disease
  • Tourette’s Syndrome
  • Other psychiatric and central nervous system conditions
  • Bipolar Disorder
  • General Anxiety Disorder

If you are interested, please contact us here.